ecl a Search Results


98
Cytiva Europe ecla prime western blotting reagents
Ecla Prime Western Blotting Reagents, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/Amersham+ECL+Prime+Western+blot+detection+reagent/us12403198-224-183-188
Average 98 stars, based on 1 article reviews
ecla prime western blotting reagents - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

99
Bio-Rad ecl a b reagents
Ecl A B Reagents, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/Clarity+Western+ECL+Substrate/pmc12634064-125-36-42
Average 99 stars, based on 1 article reviews
ecl a b reagents - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Eppendorf AG eppendorf by ecl
FIG. 4. The effects of BUdR treatment on levels of b3 integrin FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur- grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to confluence (C) in growth medium which had been cultured to subconfluence (SC) and confluence or in growth medium with or without 6.5 mM BUdR and from cells (C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under Immunoreactive bands were detected by <t>ECL</t> <t>and</t> <t>quantitated</t> Materials and Methods and quantitated using a phosphorimager. by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence (A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.
Eppendorf By Ecl, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/Eppendorf/pm09133434-102-11-11
Average 99 stars, based on 1 article reviews
eppendorf by ecl - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
Ambrx Inc bridging ecla
FIG. 4. The effects of BUdR treatment on levels of b3 integrin FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur- grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to confluence (C) in growth medium which had been cultured to subconfluence (SC) and confluence or in growth medium with or without 6.5 mM BUdR and from cells (C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under Immunoreactive bands were detected by <t>ECL</t> <t>and</t> <t>quantitated</t> Materials and Methods and quantitated using a phosphorimager. by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence (A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.
Bridging Ecla, supplied by Ambrx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/bridging+ecla/us09962450-3402-6-16
Average 90 stars, based on 1 article reviews
bridging ecla - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC meso scale discovery electrochemiluminescence assay platform
FIG. 4. The effects of BUdR treatment on levels of b3 integrin FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur- grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to confluence (C) in growth medium which had been cultured to subconfluence (SC) and confluence or in growth medium with or without 6.5 mM BUdR and from cells (C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under Immunoreactive bands were detected by <t>ECL</t> <t>and</t> <t>quantitated</t> Materials and Methods and quantitated using a phosphorimager. by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence (A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.
Meso Scale Discovery Electrochemiluminescence Assay Platform, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/meso+scale+discovery++msd++platform/pm37029141-58-21-19
Average 90 stars, based on 1 article reviews
meso scale discovery electrochemiluminescence assay platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
JIAHE INTERNATIONAL CO LTD ecla
Description of the included studies
Ecla, supplied by JIAHE INTERNATIONAL CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/ecla/pmc03506225-33-7-0
Average 90 stars, based on 1 article reviews
ecla - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC plate-based ecla
Description of the included studies
Plate Based Ecla, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/plate+based+ecla/pm24752719-42-2-4
Average 90 stars, based on 1 article reviews
plate-based ecla - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC electrochemiluminescence assays
Description of the included studies
Electrochemiluminescence Assays, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/electrochemiluminescence+assay/pmc08139699-58-33-37
Average 90 stars, based on 1 article reviews
electrochemiluminescence assays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC sequential bridging ecla
Description of the included studies
Sequential Bridging Ecla, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/sequential+bridging+ecla/pmc08856957-158-12-17
Average 90 stars, based on 1 article reviews
sequential bridging ecla - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC multiplexed ecla assays
Description of the included studies
Multiplexed Ecla Assays, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/multiplexed+ecla+assays/pmc08531985__NEJMc2115596_appendix-92-5-36
Average 90 stars, based on 1 article reviews
multiplexed ecla assays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC ecla plates meso scale discovery [msd] sars-cov-2 igg, panels 22, 23
Description of the included studies
Ecla Plates Meso Scale Discovery [Msd] Sars Cov 2 Igg, Panels 22, 23, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/v+plex+sars+cov+2+panel+2+kit/ppr0570246-178-0-2
Average 90 stars, based on 1 article reviews
ecla plates meso scale discovery [msd] sars-cov-2 igg, panels 22, 23 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC validated bridging ecla
Description of the included studies
Validated Bridging Ecla, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+a/validated+bridging+ecla/pmc07854299-297-10-14
Average 90 stars, based on 1 article reviews
validated bridging ecla - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


FIG. 4. The effects of BUdR treatment on levels of b3 integrin FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur- grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to confluence (C) in growth medium which had been cultured to subconfluence (SC) and confluence or in growth medium with or without 6.5 mM BUdR and from cells (C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under Immunoreactive bands were detected by ECL and quantitated Materials and Methods and quantitated using a phosphorimager. by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence (A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.

Journal: Developmental biology

Article Title: Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation.

doi: 10.1006/dbio.1997.8527

Figure Lengend Snippet: FIG. 4. The effects of BUdR treatment on levels of b3 integrin FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur- grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to confluence (C) in growth medium which had been cultured to subconfluence (SC) and confluence or in growth medium with or without 6.5 mM BUdR and from cells (C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under Immunoreactive bands were detected by ECL and quantitated Materials and Methods and quantitated using a phosphorimager. by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence (A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.

Article Snippet: Cells (4 1 105 cells in 1 ml) were added to eppendorf by ECL (a) and quantitated by JAVA video analysis as graphically represented (b).

Techniques: Quantitation Assay, Expressing, Cell Culture, Control, Western Blot, Northern Blot

Description of the included studies

Journal: Archives of Medical Science : AMS

Article Title: Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population

doi: 10.5114/aoms.2012.30831

Figure Lengend Snippet: Description of the included studies

Article Snippet: Jiahe, 2008 [ ] , 56 , ECLA , 20 μg/l , 65 , 90.

Techniques: Enzyme-linked Immunosorbent Assay

Summary data from the 17 studies of the utility of CYFRA 21-1 in the differential diagnosis of MPE and BPE

Journal: Archives of Medical Science : AMS

Article Title: Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population

doi: 10.5114/aoms.2012.30831

Figure Lengend Snippet: Summary data from the 17 studies of the utility of CYFRA 21-1 in the differential diagnosis of MPE and BPE

Article Snippet: Jiahe, 2008 [ ] , 56 , ECLA , 20 μg/l , 65 , 90.

Techniques: Biomarker Discovery, Enzyme-linked Immunosorbent Assay